Cargando…
Short‐term clinical observations of belimumab in the treatment of recently diagnosed systemic lupus erythematosus
OBJECTIVE: To explore the therapeutic effectiveness and safety of belimumab in the treatment of recently diagnosed systemic lupus erythematosus (SLE). METHODS: Between January 2019 and February 2022, a total of 30 patients who had been recently diagnosed with SLE were selected for 6 months of belimu...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601783/ https://www.ncbi.nlm.nih.gov/pubmed/36301032 http://dx.doi.org/10.1002/iid3.716 |